Related by context. Frequent words. (Click for all words.) 81 Qualifying Therapeutic Discovery 76 Therapeutic Discovery Project 74 QTDP 60 Orphan Products 60 FDA Orphan Drug 60 Orphan Drug Designation 60 CFFT 59 SBIR grant 59 SBIR Phase 59 Orphan Drug Status 59 Orphan Drug designation 59 Celladon 58 RNAi Therapeutics 58 Inc. Nasdaq IMGN 58 forodesine 58 Fast Track Designation 57 Amarillo Biosciences 57 Protexia R 57 Regulus Therapeutics 57 Phase IIB 57 FoldRx 57 Repligen Corporation 57 Ore Pharmaceuticals 57 Panzem R 56 Addrenex 56 OncoGenex Pharmaceuticals Inc. 56 ZALBIN 56 drug conjugate ADC 56 Project BioShield Act 56 FDA Accepts 56 DNA RNA Medicines 56 IMC #B 56 NASDAQ DYAX 56 RegeneRx Biopharmaceuticals Inc. 56 NEUMUNE 55 BioDelivery Sciences 55 HCV protease inhibitor 55 Myrexis 55 Metabasis Therapeutics Inc. 55 Alseres 55 Nasdaq VRTX 55 IDRI 55 Orphan Drug status 55 Diabetic Macular Edema 55 Investigational Device Exemption 55 Exclusive License 55 Committed Equity 55 BioSeek 55 Chemokine Therapeutics 55 Complete Response 55 PEG SN# 55 Research CIHR 55 BioMarin Genzyme LLC 55 orphan designation 55 ToxCast 54 Vandetanib 54 Ultra Deepwater 54 Pivotal Phase III 54 XTENT 54 therapeutic monoclonal antibodies 54 Humanetics 54 Ligand Pharmaceuticals Incorporated 54 Chemokine 54 JAK3 54 Progenics Pharmaceuticals 54 Trubion Pharmaceuticals 54 Genaera Corporation 54 Warrant Exercise 54 Anacor 54 Phenomix 54 Sunesis Pharmaceuticals 54 Belinostat 54 Transave 54 Neogenix Oncology 54 Epratuzumab 54 MJFF 54 Pirfenidone 54 Archemix Corp. 54 Small Molecule 54 sodium Injection 54 metastatic hormone refractory 54 phase IIb clinical 53 Cleveland BioLabs 53 Pharmion Corporation 53 Oncolin 53 Allovectin 7 R 53 RiVax ™ 53 Lexicon Genetics 53 Ixempra 53 Million Stock Repurchase 53 Ceregene 53 Critical Outcome Technologies 53 IoGen 53 Fibrillex TM 53 Innovation CFI 53 PATH Malaria Vaccine Initiative 53 Presents Positive 53 Apricus Bio 53 Patient Enrollment 53 Harbor BioSciences 53 IR BioSciences Holdings